MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Medtronic plc
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026
$92.77−1.98 (-2.09%)
Close on Oct 19, 2026
- Market cap
- $119.22B
- P/E (TTM)
- 22.8
- Dividend yield
- 3.06%
Share price
−$3.01 (−3.14%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Medtronic plc grew revenue 9.8% to $37.54B over the twelve months to Jul 31, 2026. Operating income rose 10.9% to $6.79B, moving the operating margin from 17.9% to 18.1%. Free cash flow was $6.13B, up 15.6% from a year earlier.
Revenue
$37.54B
+9.8% vs. a year earlier
Operating income
$6.79B
+10.9% vs. a year earlier
Free cash flow
$6.13B
+15.6% vs. a year earlier
EPS, diluted
$4.07
+12.1% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $119.22B
- P/E ratio
- 22.8
- Price to sales
- 3.18
- Price to book
- 2.37
- Dividend yield
- 3.06%
- Free cash flow yield
- 5.14%
Fundamentals
- Revenue
- $37.54B
- Net income
- $5.23B
- EPS, diluted
- $4.07
- Free cash flow
- $6.13B
- Book value per share
- $39.09
- Diluted shares
- 1.29B
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
$37.54B+9.8% YoY
Gross profit
$24.41B+9.3% YoY
Operating income
$6.79B+10.9% YoY
Net income
$5.23B+12.3% YoY
EPS, diluted
$4.07+12.1% YoY
Free cash flow
$6.13B+15.6% YoY
Reported periodTrailing twelve months